Physician profile
Rachael E Proctor
NPI 1730133034
$1,281.37
in general payments reported to CMS, 2019-2025
22 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $46.59 · 2021: $36.11 · 2022: $87.42 · 2023: $403 · 2024: $225 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.02 |
| Education | $175.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $498.45 | 2019-2025 | Veozah |
| Abbvie INC. | $187.45 | 2019-2023 | |
| Pfizer INC. | $73.43 | 2022-2024 | |
| Hologic Sales and Service, LLC | $65.85 | 2021-2023 | Coolseal Generator, Acessa Provu System, Novasure |
| Exeltis, USA INC. | $59.02 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $50.29 | 2020-2025 | |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Axonics, INC. | $39.79 | 2023 | Axonics |
| Amag Pharmaceuticals, INC. | $27.97 | 2019 | |
| Merck Sharp & Dohme LLC | $27.33 | 2024 | Gardasil, Gardasil 9 |
| Minerva Surgical, INC | $23.96 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $23.77 | 2025 | Exparel |
| Femselect INC. | $21.64 | 2025 | Enplace |
| Sumitomo Pharma America, INC. | $21.37 | 2025 | Myfembree |
| Glaxosmithkline, LLC. | $20.45 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $19.87 | 2023 | |
| Exact Sciences Corporation | $14.88 | 2023 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $13.90 | 2025 | Pico 7 |
| Boston Scientific Corporation | $13.89 | 2020 | |
| Medicem INC. | $13.01 | 2023 | |
| Ibsa Pharma INC. | $12.80 | 2023 | Tirosint, Licart |
| Allergan, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachael Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.